Membrane Transport: Riding elevators into and out of cells
Small carboxylate ions such as citrate and succinate are intermediates in the citric acid cycle, which is a crucial metabolic pathway in aerobic organisms. However, small carboxylate ions also have many other roles: for example, they function as signaling molecules in processes ranging from DNA transcription and replication (Wellen et al., 2009) to heat generation (Mills et al., 2018), and they have also been linked to obesity (Birkenfeld et al., 2011) and seizures (Thevenon et al., 2014).
Cells rely on transmembrane proteins belonging to the DASS family (short for divalent anion sodium symporter) to move small carboxylate ions into and out of cells. There are two clades in the DASS family: cotransporters that import carboxylate ions from the bloodstream into cells (Prakash et al., 2003), and antiporters/exchangers that move some carboxylate ions into cells while moving others out (Pos et al., 1998).
Previously the structure of just one member of the DASS family – a cotransporter called VcINDY, which is found in the bacterium Vibrio cholerae – had been determined (Mancusso et al., 2012; Mulligan et al., 2016; Nie et al., 2017). VcINDY contains two subunits, and each of these contains two domains: (i) a scaffold domain, which is anchored in the plasma membrane of the cell and is not, therefore, free to move; (ii) a transport domain, which is more mobile.
It has been predicted that DASS proteins operate with an 'elevator mechanism' that involves the transport domain (to which the carboxylate ion is attached) sliding up and down the scaffold domain between an inward-facing state and an outward-facing state (Figure 1; Mulligan et al., 2016). However, since the structure of VcINDY has only ever been determined for the inward-facing state, evidence in support of this mechanism has remained inconclusive. Now, in eLife, Da-Neng Wang (New York University School of Medicine), Emad Tajkhorshid (University of Illinois at Urbana-Champaign) and co-workers – including David Sauer as first author – report the results of a combined experimental and computational study that helps to shed light on this mystery (Sauer et al., 2020).
The researchers used a combination of X-ray crystallography and cryo-electron microscopy to determine structures for VcINDY and also for LaINDY, an antiporter that is found in the bacterium Lactobacillus acidophilus. Remarkably, they were able to obtain structures for the previously elusive outward-facing state for both. Moreover, they determined the structures when a carboxylate ion was bound to the transport domain and also for the substrate-free case. Relative to the inward-facing state, the transport domain in the outward-facing state is rotated by an angle of 37° and is about 13 Å further away from the inside of the cell (Figure 1).
Sauer et al. then used computer simulations to model the transition from an initial state in which two succinate ions were bound to the outward-facing state in the LaINDY antiporter (based on their experimental structures) to a final state in which the succinate ions were inside the cell and the antiporter was in an inward-facing state: the researchers used an approximate structure for the final state as the actual structure for the inward-facing state in LaINDY has not been determined yet. Jointly, the experiments and simulations lend strong support to the elevator mechanism.
One may ask: how does the cotransporter or antiporter make sure that the carboxylate ion has been loaded into the elevator before the button is pressed? The experimental structures suggest that a 'passport check' is enforced via electrostatic effects. In the absence of the carboxylate ion, the binding site on the transport domain has a positive net charge, which makes it difficult for this domain to pass through the membrane, because charged particles prefer polar environments (such as aqueous solutions) to the nonpolar environments found in the membrane. Loading the negative carboxylate ion onto the binding site neutralizes the postive charge, allowing the transport domain to cruise through. This mechanism limits a form of unproductive transport called slippage (that is, the passage of substrate-free transport domains) in both cotransporters and antiporters.
The work of Sauer et al. also highlights interesting differences between the cotransporter and the antiporter. For the VcINDY cotransporter the positive charge on the transport domain is provided by sodium ions, and the binding of the carboxylate ion to the transport domain leads to large changes in conformation. It also appears that the relatively weak initial binding of sodium ions in the cotransporter is strengthened by the arrival of the carboxylate ion. In contrast, the positive charges in the LaINDY antiporter are provided by amino acid residues rather than sodium ions, and the conformational changes caused by binding appeared to be small and local.
It would be interesting to explore the effects of introducing mutations to the residues at the sites of the sodium ions in VcINDY cotransporters or the equivalent sites in LaINDY antiporters. Would it be possible to engineer a sodium-independent cotransporter? And could a cotransporter be converted into an antiporter, and vice versa? Answers to these questions will lead to a deeper understanding of the structure-function relationships for proteins belonging to the DASS family.
References
-
The bacterial dicarboxylate transporter VcINDY uses a two-domain elevator-type mechanismNature Structural & Molecular Biology 23:256–263.https://doi.org/10.1038/nsmb.3166
-
The ion transporter superfamilyBiochimica et Biophysica Acta (BBA) - Biomembranes 1618:79–92.https://doi.org/10.1016/j.bbamem.2003.10.010
-
Mutations in SLC13A5 cause autosomal-recessive epileptic encephalopathy with seizure onset in the first days of lifeAmerican Journal of Human Genetics 95:113–120.https://doi.org/10.1016/j.ajhg.2014.06.006
Article and author information
Author details
Publication history
Copyright
© 2020, Duster and Lin
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 701
- views
-
- 80
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Structural Biology and Molecular Biophysics
Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor transcription factor that regulates gene expression programs in response to ligand binding. Endogenous and synthetic ligands, including covalent antagonist inhibitors GW9662 and T0070907, are thought to compete for the orthosteric pocket in the ligand-binding domain (LBD). However, we previously showed that synthetic PPARγ ligands can cooperatively cobind with and reposition a bound endogenous orthosteric ligand to an alternate site, synergistically regulating PPARγ structure and function (Shang et al., 2018). Here, we reveal the structural mechanism of cobinding between a synthetic covalent antagonist inhibitor with other synthetic ligands. Biochemical and NMR data show that covalent inhibitors weaken—but do not prevent—the binding of other ligands via an allosteric mechanism, rather than direct ligand clashing, by shifting the LBD ensemble toward a transcriptionally repressive conformation, which structurally clashes with orthosteric ligand binding. Crystal structures reveal different cobinding mechanisms including alternate site binding to unexpectedly adopting an orthosteric binding mode by altering the covalent inhibitor binding pose. Our findings highlight the significant flexibility of the PPARγ orthosteric pocket, its ability to accommodate multiple ligands, and demonstrate that GW9662 and T0070907 should not be used as chemical tools to inhibit ligand binding to PPARγ.
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.